|
UMIN-CTR History |
|
 UMIN-CTR English Home |
Glossary (Simple) |
FAQ |
Search clinical trials |
| Name: | UMIN ID: |
| Unique ID issued by UMIN | UMIN000031684 |
| Receipt No. | R000036186 |
| Scientific Title | Phase 1 study of RK-163 pulsed human autologous CD14-positive cells (RK-CD14MO) for patients with advanced or relapsed solid tumor |
| Date of disclosure of the study information | 2018/03/12 |
| Last modified on | 2020/05/15 11:21:26 |
| No. | Disposal | Last modified on | Item of update | |
| 1 | Insert | 2018/03/12 16:17:50 | ||
| 2 | Update | 2018/03/12 22:31:46 | Public title Acronym |
|
| 3 | Update | 2018/03/12 22:33:02 | Narrative objectives1 Primary outcomes |
|
| 4 | Update | 2018/03/12 22:36:00 | Interventions/Control_1 Key inclusion criteria Key exclusion criteria |
|
| 5 | Update | 2018/03/12 22:37:20 | Organization |
|
| 6 | Update | 2018/03/13 12:18:37 | Last name of contact person Last name of contact person Division name Division name TEL |
|
| 7 | Update | 2018/03/13 12:19:21 | Classification by specialty |
|
| 8 | Update | 2018/03/15 16:33:54 | Classification by specialty |
|
| 9 | Update | 2018/03/26 11:57:39 | Division name |
|
| 10 | Update | 2020/05/15 11:21:26 | Recruitment status Date of IRB Last follow-up date |
